CTI BIOPHARMA CORP (CTIC)       5.72  -0.1 (-1.72%)

5.72  -0.1 (-1.72%)

US12648L6011 - Common Stock - After market: 5.72 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.13 -0.16 0.0318.65% Q2 2022 -0.21 -0.21 0.00-2.21% Q1 2022 -0.37 -0.42 0.0512.38% Q4 2021 -0.38 -0.29 -0.09-32.26% Q3 2021 -0.26 -0.25 -0.01-2.65% Q2 2021 -0.21 -0.21 0.001.96% Q1 2021 -0.23 -0.22 -0.01-3.67% Q4 2020 -0.20 -0.16 -0.04-24.49%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.76 -1.08 30.01%Q4 2022 -0.10 -0.38 74.95%FY 2023 -0.01 -0.76 98.31%Q1 2023 -0.06 -0.37 83.46%Q2 2023 -0.02 -0.21 91.50%Q3 2023 0.02 -0.13 111.77%Q4 2023 0.06 -0.10 161.61%FY 2024 0.61 -0.01 4,886.64%FY 2025 0.84 0.61 38.30%FY 2026 1.24 0.84 47.43%FY 2027 2.25 1.24 81.15%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 18.241M 17.511M 730K4.17% Q2 2022 12.329M 9.279M 3.05M32.87% Q1 2022 2.295M 1.571M 724K46.09% Q4 2021 % Q3 2021 % Q2 2021 % Q1 2021 % Q4 2020 %
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 58.645M %Q4 2022 24.532M %FY 2023 160.65M 58.645M 173.94%Q1 2023 28.248M 2.295M 1,130.85%Q2 2023 34.941M 12.329M 183.40%Q3 2023 43.956M 18.241M 140.97%Q4 2023 53.715M 24.532M 118.96%FY 2024 303.07M 160.65M 88.65%FY 2025 404.7M 303.07M 33.53%FY 2026 539.63M 404.7M 33.34%FY 2027 731.92M 539.63M 35.63%FY 2028 793.2M 731.92M 8.37%FY 2029 896.11M 793.2M 12.97%FY 2030 979.32M 896.11M 9.29%